Four patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2031. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Dec 2031
Next term end
3
Patent families
When these terms end
Each bar runs from grant to computed term end. 2015 to 2042.20212027203320392042
6 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Dec 2031 · High confidence
Also notable
Ends Aug 2032 · High confidence
Also notable
Ends Sep 2042 · High confidence
Methods and Means for Molecular Classification of Colorectal Cancers
US 10,036,070
Granted 2018 and renewed at every maintenance window due so far. Protection runs to 2031.
Means and Methods for Molecular Classification of Breast Cancer
US 9,175,351
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2032.
Methods of Assessing Diseases Using Image Classifiers
US 11,954,859
Granted 2024. Too new for citation comparison; protection runs to 2042.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 3, 2027The maintenance fee for Means and Methods for Molecular Classification of Breast Cancer (US 9,175,351) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.
- 1 fee due Oct 9, 2027The maintenance fee for Methods of Assessing Diseases Using Image Classifiers (US 11,954,859) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 2 largest of its 3 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Means and Methods for Molecular Classification of Breast Cancer | 2 in force | to Aug 2032 |
| Methods and Means for Molecular Classification of Colorectal Cancers | 1 in force | to Dec 2031 |
Patents held now
Soonest term end first.
Showing 1 to 4 of 4
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,036,070 | Methods and Means for Molecular Classification of Colorectal Cancers In force · High confidence | In force | High confidence | |
| US 9,175,351 | Means and Methods for Molecular Classification of Breast Cancer In force · High confidence | In force | High confidence | |
| US 10,072,301 | Means and Methods for Molecular Classification of Breast Cancer In force · High confidence | In force | High confidence | |
| US 11,954,859 | Methods of Assessing Diseases Using Image Classifiers In force · High confidence | In force | High confidence |
Also on record, not counted in the 4: 3 patents ended · 6 applications pending · 13 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.